Company intelligence / Profile preview

Primity Bio

Fremont, California, United States

Ownership: Private
Employees: ~3
Development stage: Other

Overview

Primity Bio is a specialized provider of biomarker discovery and immune monitoring services using advanced flow cytometry, FACS, and CyTOF for pre-clinical and clinical drug development, now operating as part of Caprion Biosciences.[1][2][5][6]

Modalities: BiologicCell therapyVaccineSmall molecule
Industry: Drug Discovery Services

Partnerships

Biopharma clients for biomarker discovery, early drug discovery, pre-clinical and clinical immune monitoring (names generally undisclosed)

Beyond the preview

Go deeper on Primity Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Primity Bio.

Explore the full profile